Form 4: Pediatrix Medical Group Director, Shirley A. Weis, Reports Acquisition and Disposal of Common Stock

Director Shirley A. Weis reports acquiring and disposing of Pediatrix Medical Group, Inc. common stock on May 9, 2024, according to a Form 4 filing with the SEC.

Summary

• On May 9, 2024, Shirley A. Weis, a director of Pediatrix Medical Group, Inc., reported acquiring 18,360 shares of common stock at $0 and disposing of shares.
• Following the transaction, Weis beneficially owns 36,028 shares of common stock.
• The acquisition of 18,360 shares was due to restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award.
• These shares will vest on May 9, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard insider transactions and alignment of interests. There are no indications of negative events or concerns.

Positives

• The acquisition of shares reflects a continued alignment of the director's interests with the company's performance.

Future Outlook

The director's holdings will increase upon vesting of the restricted shares on May 9, 2025.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the director's stake in the company.

Key Dates